Curamuse Neo Dry Syrup (Amoxicillin-Clavulanate Potassium (14:1))
Amoxicillin Hydrate 54.55g · Dilute Potassium Clavulanate 3.9g
Syrup · Prescription medication · Combination
Jeongwoo Pharmaceutical Co., Ltd.
MFDS item code 201900854 · Notified 2019.02.11
This product's status changed to Expired on 2024.01.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of recurrent or persistent acute otitis media and recurrent acute rhinosinusitis in children
This medication is effective against important bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is particularly used for the treatment of recurrent or persistent acute otitis media and acute sinusitis in pediatric patients. It is recommended for pediatric patients who have had antibiotic treatment experience within the last 3 months and are under 2 years old or attending daycare. This medication helps to improve the symptoms of otitis media and sinusitis in children with risk factors.
○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Caution should be exercised when administering this drug to patients with hepatic impairment, and liver function should be monitored regularly. ○ This drug should be administered at the beginning of a meal to minimize the possibility of gastrointestinal disturbances. Administration of this drug at the beginning of a meal increases the absorption of potassium clavulanate.
○ Pediatric patients aged 3 months and older: The recommended dose of this drug, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in divided doses every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.
This medication contains the artificial sweetener aspartame and should not be used by patients with the hereditary disease phenylketonuria. The intake of aspartame should be controlled below the WHO recommended amount, and for a 60kg adult, the maximum daily dosage can be up to 2.4g. Patients who have had hypersensitivity reactions to the components of this drug or to beta-lactam antibiotics, patients with infectious mononucleosis or lymphocytic leukemia, patients with a history of liver dysfunction or jaundice, and those with genetic issues such as lactose intolerance should not be administered this medication. Patients with impaired liver or kidney function, patients with allergies, elderly patients, patients who have difficulty taking orally, and patients with gastrointestinal diseases should use this medication cautiously. This medication can cause adverse reactions primarily in the gastrointestinal tract, such as diarrhea, vomiting, and rash, and various side effects have been reported including liver function anomalies, hypersensitivity reactions, hematologic anomalies, and neurological anomalies, so if abnormal symptoms occur, the patient should consult a doctor immediately. To prevent the occurrence of resistant bacteria, it is advisable to take this medication only for the minimum necessary duration after susceptibility testing, and those with a history of penicillin hypersensitivity should be especially careful. After administration, severe allergic reactions such as anaphylaxis may occur, and the patient's condition should be closely monitored, and if acute symptoms appear, immediate first aid should be provided. If severe diarrhea or abdominal pain occurs during or after antibiotic use, it is necessary to consider the possibility of pseudomembranous colitis and to stop taking the medication and consult medical personnel. This medication can lead to excessive growth of non-susceptible bacteria with prolonged use, so caution is needed if used for more than 14 days. Patients with liver disease should use this medication carefully as abnormalities may appear in liver function tests, and dose adjustment is necessary for patients with renal impairment. It should be avoided during the first three months of pregnancy, and during breastfeeding, if side effects occur in infants, the medication should be discontinued. Safety and efficacy have not been established in infants under 3 months, so it should not be used in this population. This medication may interact with other drugs, so if taking other medications, it must be reported to a doctor or pharmacist, especially when used in conjunction with anticoagulants or certain antibiotics. In case of overdose, gastrointestinal symptoms, kidney function impairment, and seizures may occur, so immediate cessation and appropriate treatment must be administered, and adequate hydration is crucial. Before use, the medication should be shaken well, and after preparation, it should be stored in the refrigerator and used within 7 days. Keep out of reach of children, avoid direct sunlight, and store in a dry place.
Contact dermatitis, diaper rash, diarrhea, vomiting, moniliasis, rash, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, melena, dry mouth, candidiasis, antibiotic-associated colitis, AST elevation, ALT elevation, ALP elevation, LDH elevation, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, burning sensation, increased secretions, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, tooth discoloration, taste disturbance, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, hyperactivity, interstitial nephritis, hypersensitivity shock, skin reactions, bleeding, pancytopenia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The storage location should be a dry place between 1°C and 25°C that is not too hot or humid.
A syrup preparation that dissolves into a liquid when used, with bright white powder and a peculiar smell.
50mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amoxicillin Hydrate 54.55g · Dilute Potassium Clavulanate 3.9g
Syrup · Prescription medication · Combination
Jeongwoo Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 125mg · Dilute Potassium Clavulanate 107.76mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Dong Sung Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.